Command Palette

Search for a command to run...

BIOCON

360.255.35 (1.51%)

Quarterly ResultsProfit & LossBalance SheetCash Flow

Key Insights

POSITIVE
  • Significant rise in net sales to ₹4417 crore in Q1 202503, up from ₹3821.4 crore last quarter.
  • Operating margin improved substantially to 9.72% this quarter, reflecting enhanced operational efficiency.
  • Net profit surged to ₹459.4 crore, showcasing a strong recovery compared to previous quarters.
NEGATIVE
  • Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
  • Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
  • Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
FieldTrendSep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25
Revenue
3,462.303,953.703,917.103,432.903,590.403,821.404,4173,941.90
Expenses
3,357.703,708.103,635.203,453.903,550.503,718.403,987.503,924.70
Operating Profit
104.60245.60281.90-2139.90103429.5017.20
Other Income
157.90565.5048.601,134.5032.5034.8036.9079.70
Interest
247.70266.70227236225.60223.40212.40276.70
Depreciation
389.30414.50407405.40419.90425.40436.30455
Profit Before Tax
214.30808.203191,145.5098.40155.90486.8096.90
Tax
41.6054.9096.10283.7071.3074.8027.407.70
Net Profit
172.70753.30222.90861.8027.1081.10459.4089.20
EPS in Rs
1.055.521.135.51-0.130.212.880.26